Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2006 2
2007 1
2010 2
2013 1
2014 2
2018 2
2019 1
2020 3
2021 6
2022 5
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Inotuzumab Ozogamicin as Induction Therapy for Patients Older Than 55 Years With Philadelphia Chromosome-Negative B-Precursor ALL.
Stelljes M, Raffel S, Alakel N, Wäsch R, Kondakci M, Scholl S, Rank A, Hänel M, Spriewald B, Hanoun M, Martin S, Schwab K, Serve H, Reiser L, Knaden J, Pfeifer H, Marx J, Sauer T, Berdel WE, Lenz G, Brüggemann M, Gökbuget N, Wethmar K. Stelljes M, et al. Among authors: wethmar k. J Clin Oncol. 2024 Jan 20;42(3):273-282. doi: 10.1200/JCO.23.00546. Epub 2023 Oct 26. J Clin Oncol. 2024. PMID: 37883727 Clinical Trial.
Loss-of-function uORF mutations in human malignancies.
Schulz J, Mah N, Neuenschwander M, Kischka T, Ratei R, Schlag PM, Castaños-Vélez E, Fichtner I, Tunn PU, Denkert C, Klaas O, Berdel WE, von Kries JP, Makalowski W, Andrade-Navarro MA, Leutz A, Wethmar K. Schulz J, et al. Among authors: wethmar k. Sci Rep. 2018 Feb 5;8(1):2395. doi: 10.1038/s41598-018-19201-8. Sci Rep. 2018. PMID: 29402903 Free PMC article.
Complete Metabolic Response to Combined Immune Checkpoint Inhibition after Progression of Metastatic Colorectal Cancer on Pembrolizumab: A Case Report.
Krekeler C, Wethmar K, Mikesch JH, Kerkhoff A, Menck K, Lenz G, Schildhaus HU, Wessolly M, Hoffmann MW, Pascher A, Asmus I, Wardelmann E, Bleckmann A. Krekeler C, et al. Among authors: wethmar k. Int J Mol Sci. 2023 Jul 27;24(15):12056. doi: 10.3390/ijms241512056. Int J Mol Sci. 2023. PMID: 37569431 Free PMC article.
Temporal autoregulation during human PU.1 locus SubTAD formation.
Schuetzmann D, Walter C, van Riel B, Kruse S, König T, Erdmann T, Tönges A, Bindels E, Weilemann A, Gebhard C, Wethmar K, Perrod C, Minderjahn J, Rehli M, Delwel R, Lenz G, Gröschel S, Dugas M, Rosenbauer F. Schuetzmann D, et al. Among authors: wethmar k. Blood. 2018 Dec 20;132(25):2643-2655. doi: 10.1182/blood-2018-02-834721. Epub 2018 Oct 12. Blood. 2018. PMID: 30315124 Free article.
Author Correction: Loss-of-function uORF mutations in human malignancies.
Schulz J, Mah N, Neuenschwander M, Kischka T, Ratei R, Schlag PM, Castaños-Vélez E, Fichtner I, Tunn PU, Denkert C, Klaas O, Berdel WE, von Kries JP, Makalowski W, Andrade-Navarro MA, Leutz A, Wethmar K. Schulz J, et al. Among authors: wethmar k. Sci Rep. 2021 Jan 28;11(1):2917. doi: 10.1038/s41598-021-82176-6. Sci Rep. 2021. PMID: 33510296 Free PMC article. No abstract available.
Characteristics and Outcome of Elderly Patients (>55 Years) with Acute Lymphoblastic Leukemia.
Wenge DV, Wethmar K, Klar CA, Kolve H, Sauer T, Angenendt L, Evers G, Call S, Kerkhoff A, Khandanpour C, Kessler T, Mesters R, Schliemann C, Mikesch JH, Reicherts C, Brüggemann M, Berdel WE, Lenz G, Stelljes M. Wenge DV, et al. Among authors: wethmar k. Cancers (Basel). 2022 Jan 23;14(3):565. doi: 10.3390/cancers14030565. Cancers (Basel). 2022. PMID: 35158832 Free PMC article.
27 results